Proteomic Insights Into Moxifloxacin Efficacy and Resistance in Vibrio parahaemolyticus
Abstract
The emergence of multidrug-resistant Vibrio parahaemolyticus poses major public health challenges, necessitating new treatment strategies. This research uses quantitative proteomics to explore the underlying antibiotic stress response mechanisms of moxifloxacin (Mox), a broad-spectrum fluoroquinolone, which effectively targets clinically resistant strains. After exposing bacteria to 1/2 MIC of Mox (2.5 ng/ml), proteomic analysis revealed significant changes in differentially expressed proteins (DEPs). These DEPs were enriched in several gene ontology (GO) and KEGG pathways, including SOS responses, cellular response to external stimuli, DNA helicase complexes, and transmembrane transport. KEGG analysis also indicated involvement in alanine, aspartate, and glutamate metabolism. PPI analysis revealed that many DEPs participated in quorum sensing (VP0047, VP0048, VP2088, VP0050, VP0049, and VP2091 downregulated), amino acid metabolism (VP1772, VP0483, VP0481, VP0826, ArgH, VP0484 downregulated, while CarA and CarB were upregulated), and kinase activity (VP0364, VP0365, VP0366, VP1190 downregulated; VP0370, VP1688, VPA0094, VPA0095, MltD, and Flg2 upregulated). Under Mox treatment, V. parahaemolyticus increased production of fluoroquinolone resistance proteins (VP1315 and VPA0095) and multidrug efflux components (VPA1190 and VPA1191), shifting from efflux-based resistance toward DNA repair mechanisms that maintain genome stability under fluoroquinolone stress. These proteomic…
Read the paper
Related studies
- Synthesis, In Vitro and In Silico Molecular Docking Studies of Novel Phthalimide–Pyrimidine Hybrid Analogues to Thalidomide as Potent Antitubercular Agents
- Exploring the inhibitory performance of expired moxifloxacin and norfloxacin on copper corrosion in saline environment
- Molecular investigation of antimicrobial peptides against Helicobacter pylori proteins using a peptide-protein docking approach
- Screening of novel narrow-spectrum benzofuroxan derivatives for the treatment of multidrug-resistant tuberculosis through in silico, in vitro, and in vivo approaches
- Synthesis, Characterization, Anticancer, Antioxidant, and In Silico Evaluation of Semicarbazides and Thiosemicarbazides
- Fast and accurate prediction of drug induced proarrhythmic risk with sex specific cardiac emulators
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.